X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23716) 23716
Publication (3990) 3990
Book Review (987) 987
Book Chapter (44) 44
Dissertation (23) 23
Conference Proceeding (22) 22
Magazine Article (5) 5
Data Set (4) 4
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22782) 22782
proto-oncogene proteins c-akt - metabolism (17636) 17636
humans (16324) 16324
animals (14375) 14375
mice (9166) 9166
phosphorylation (8153) 8153
signal transduction (8117) 8117
phosphatidylinositol 3-kinases - metabolism (6940) 6940
cell line, tumor (6609) 6609
apoptosis (6008) 6008
male (6008) 6008
cell biology (5933) 5933
proto-oncogene proteins c-akt - genetics (5807) 5807
female (5661) 5661
oncology (5466) 5466
signal transduction - drug effects (4925) 4925
biochemistry & molecular biology (4906) 4906
activation (4699) 4699
expression (4693) 4693
akt (4518) 4518
cancer (3914) 3914
proteins (3435) 3435
rats (3327) 3327
apoptosis - drug effects (3263) 3263
proto-oncogene proteins c-akt (3261) 3261
cells, cultured (3230) 3230
kinases (3178) 3178
cell proliferation (3105) 3105
akt protein (2845) 2845
cell line (2806) 2806
gene expression (2758) 2758
proto-oncogene proteins - metabolism (2612) 2612
research (2543) 2543
cell proliferation - drug effects (2514) 2514
phosphorylation - drug effects (2375) 2375
article (2355) 2355
growth (2148) 2148
pathway (2145) 2145
phosphatidylinositol 3-kinases - genetics (2116) 2116
proto-oncogene proteins c-akt - antagonists & inhibitors (2098) 2098
research article (2093) 2093
blotting, western (2085) 2085
signal transduction - physiology (2067) 2067
cells (2012) 2012
mice, inbred c57bl (2004) 2004
analysis (1975) 1975
tor serine-threonine kinases - metabolism (1975) 1975
transfection (1957) 1957
multidisciplinary sciences (1932) 1932
inhibition (1922) 1922
gene expression regulation, neoplastic (1893) 1893
mutation (1885) 1885
protein-serine-threonine kinases - metabolism (1881) 1881
enzyme activation (1850) 1850
mice, knockout (1809) 1809
medicine (1797) 1797
rna interference (1794) 1794
phosphatidylinositol 3-kinases - antagonists & inhibitors (1779) 1779
genetic aspects (1766) 1766
rodents (1754) 1754
proliferation (1742) 1742
physiological aspects (1707) 1707
middle aged (1694) 1694
survival (1633) 1633
cell survival - drug effects (1590) 1590
antineoplastic agents - pharmacology (1586) 1586
down-regulation (1565) 1565
extracellular signal-regulated map kinases - metabolism (1565) 1565
metastasis (1551) 1551
protein-serine-threonine kinases (1547) 1547
health aspects (1526) 1526
science (1510) 1510
tumors (1504) 1504
rna, messenger - metabolism (1491) 1491
up-regulation (1489) 1489
gene-expression (1473) 1473
insulin (1471) 1471
disease models, animal (1446) 1446
oxidative stress (1426) 1426
phosphatidylinositol 3-kinase (1425) 1425
physiology (1412) 1412
cell cycle (1379) 1379
biology (1376) 1376
rna, messenger - genetics (1373) 1373
mice, nude (1369) 1369
in-vivo (1360) 1360
1-phosphatidylinositol 3-kinase (1325) 1325
adult (1321) 1321
time factors (1308) 1308
protein kinase inhibitors - pharmacology (1303) 1303
enzyme inhibitors - pharmacology (1288) 1288
in-vitro (1279) 1279
signal transduction - genetics (1276) 1276
cell growth (1267) 1267
cell survival (1250) 1250
nf-kappa-b (1241) 1241
signaling pathway (1240) 1240
nf-kappa b - metabolism (1229) 1229
breast cancer (1224) 1224
signaling (1219) 1219
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23515) 23515
Chinese (153) 153
Japanese (19) 19
Russian (15) 15
French (12) 12
German (3) 3
Spanish (2) 2
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Kool, Marcel and Jones, David T.W and Jäger, Natalie and Northcott, Paul A and Pugh, Trevor J and Hovestadt, Volker and Piro, Rosario M and Esparza, L. Adriana and Markant, Shirley L and Remke, Marc and Milde, Till and Bourdeaut, Franck and Ryzhova, Marina and Sturm, Dominik and Pfaff, Elke and Stark, Sebastian and Hutter, Sonja and Şeker-Cin, Huriye and Johann, Pascal and Bender, Sebastian and Schmidt, Christin and Schmidt, Sabine and Rausch, Tobias and Shih, David and Reimand, Jüri and Sieber, Laura and Wittmann, Andrea and Linke, Linda and Witt, Olaf and Witt, Hendrik and Weber, Ursula D and Zapatka, Marc and König, Rainer and Beroukhim, Rameen and Bergthold, Guillaume and van Sluis, Peter and Volckmann, Richard and Koster, Jan and Versteeg, Rogier and Wolf, Stephan and Lawerenz, Chris and Bartholomae, Cynthia C and von Kalle, Christof and Unterberg, Andreas and Herold-Mende, Christel and Hofer, Silvia and Kulozik, Andreas E and von Deimling, Andreas and Scheurlen, Wolfram and Felsberg, Jörg and Reifenberger, Guido and Hasselblatt, Martin and Crawford, John R and Grant, Gerald A and Jabado, Nada and Perry, Arie and Cowdrey, Cynthia and Croul, Sydney and Zadeh, Gelareh and Korbel, Jan O and Doz, Francois and Delattre, Olivier and Bader, Gary D and McCabe, Martin G and Collins, V. Peter and Kieran, Mark W and Cho, Yoon-Jae and Pomeroy, Scott L and Brors, Benedikt and Taylor, Michael D and Schüller, Ulrich and Korshunov, Andrey and Eils, Roland and Wechsler-Reya, Robert J and Lichter, Peter and Pfister, Stefan M and ICGC PedBrain Tumor Project
Cancer Cell, ISSN 1535-6108, 03/2014, Volume 25, Issue 3, pp. 393 - 405
Smoothened (SMO) inhibitors recently entered clinical trials for sonic-hedgehog-driven medulloblastoma (SHH-MB). Clinical response is highly variable. To... 
NERVOUS-SYSTEM | TERT PROMOTER MUTATIONS | ONCOLOGY | GROWTH | HEDGEHOG PATHWAY INHIBITOR | ITRACONAZOLE | PEDIATRIC MEDULLOBLASTOMA | CANCER | TUMORS | MOUSE MODELS | ADULT | CELL BIOLOGY | Neoplasm Transplantation | Oncogene Proteins - genetics | Humans | Zinc Finger Protein Gli2 | Child, Preschool | Molecular Sequence Data | Infant | Male | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Biphenyl Compounds - therapeutic use | Promoter Regions, Genetic - genetics | Proto-Oncogene Proteins c-akt - genetics | Tumor Suppressor Protein p53 - genetics | Young Adult | Telomerase - genetics | Hedgehog Proteins - genetics | Base Sequence | Smoothened Receptor | Adult | Female | N-Myc Proto-Oncogene Protein | Patched Receptors | Medulloblastoma - genetics | Nuclear Proteins - genetics | Proto-Oncogene Proteins c-akt - metabolism | Child | Pyridines - therapeutic use | Cerebellar Neoplasms - drug therapy | Repressor Proteins - genetics | DNA Copy Number Variations - genetics | Signal Transduction - genetics | Cerebellar Neoplasms - genetics | Mice, SCID | Phosphatidylinositol 3-Kinases - genetics | DEAD-box RNA Helicases - genetics | Drug Resistance, Neoplasm - genetics | Animals | Adolescent | Receptors, G-Protein-Coupled - antagonists & inhibitors | Mice, Inbred NOD | High-Throughput Nucleotide Sequencing | Mice | Receptors, G-Protein-Coupled - genetics | Medulloblastoma - drug therapy | Kruppel-Like Transcription Factors - genetics | Patched-1 Receptor | Receptors, Cell Surface - genetics | Genetic aspects | Nucleotide sequencing | Analysis | Medulloblastoma | Genomics | DNA sequencing | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7403, pp. 405 - 409
Journal Article
Science, ISSN 0036-8075, 2014, Volume 343, Issue 6167, pp. 189 - 193
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 05/2009, Volume 69, Issue 10, pp. 4116 - 4124
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 1, pp. 58 - 71
Activation of the PI3K-AKT pathway in tumors is modulated by negative feedback, including mTORC1-mediated inhibition of upstream signaling. We now show that... 
RAPAMYCIN | TARGET | FORKHEAD TRANSCRIPTION FACTOR | CELLS | INSULIN-RECEPTOR | ACTIVATION | ONCOLOGY | SIGNALING PATHWAY | PHOSPHORYLATION | UPSTREAM | HUMAN CANCER | CELL BIOLOGY | RNA, Small Interfering - genetics | Receptor, IGF Type 1 - metabolism | Protein Binding - genetics | Receptor, ErbB-3 - metabolism | Humans | Forkhead Transcription Factors - metabolism | Protein Binding - drug effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptor, ErbB-2 - antagonists & inhibitors | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Quinoxalines - therapeutic use | Carcinoma, Non-Small-Cell Lung - metabolism | Receptor, ErbB-3 - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Breast Neoplasms - drug therapy | Receptor, IGF Type 1 - genetics | Signal Transduction - drug effects | Mice, Nude | Models, Biological | Cell Line, Tumor | Mice | TOR Serine-Threonine Kinases | Feedback, Physiological - physiology | Quinazolines - pharmacology | Proteins - antagonists & inhibitors | Neoplasms - metabolism | Gene Expression - drug effects | Multiprotein Complexes | Receptor, ErbB-2 - metabolism | Promoter Regions, Genetic - genetics | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Mechanistic Target of Rapamycin Complex 1 | Quinoxalines - pharmacology | Receptor, Insulin - genetics | Female | Forkhead Transcription Factors - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Drug Therapy, Combination | Gene Expression Regulation, Neoplastic - physiology | Carcinoma, Non-Small-Cell Lung - pathology | Up-Regulation - genetics | Forkhead Transcription Factors - genetics | Xenograft Model Antitumor Assays | Animals | Receptor Protein-Tyrosine Kinases - genetics | Breast Neoplasms - pathology | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Feedback, Physiological - drug effects | Receptor, Insulin - metabolism | Signal Transduction - physiology | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Benzylamines - pharmacology | Benzylamines - therapeutic use | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Index Medicus
Journal Article
Cancer Discovery, ISSN 2159-8274, 01/2014, Volume 4, Issue 1, pp. 80 - 93
Journal Article
Cell Metabolism, ISSN 1550-4131, 2007, Volume 6, Issue 6, pp. 458 - 471
Journal Article